Alangcas, Jhon Cloyd L.

HRN: 23-44-93  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/12/2024
CEFUROXIME 750MG (VIAL)
10/12/2024
10/19/2024
IV
400
EVERY 8 HOURS
PCAP B
Waiting Final Action 

Indication:  Empiric    Type of Infection:  PneumoniaFebrile Neutropenia    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: